BioNTech SE (BNTX) Change in Inventory (2018 - 2025)
BioNTech SE (BNTX) posted Change in Inventory of $135.3 million for Q4 2025, up 2168.66% sequentially from $6.0 million in Q3 2025, and up 536.08% YoY from $21.3 million in Q4 2024.
BioNTech SE (BNTX) Change in Inventory (2018 - 2025) Analysis & Trends
BioNTech SE has reported Change in Inventory for 8 years, with the latest figure at $135.3 million in Q4 2025.
- Quarterly Change in Inventory rose 536.08% year-over-year to $135.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $202.6 million (up 150.2% YoY) and the FY2025 annual result came in at $201.0 million, up 152.47% from the prior year.
- Change in Inventory advanced to $135.3 million in Q4 2025 per BNTX's latest filing, from $6.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $135.3 million in Q4 2025 and troughed at -$388.3 million in Q3 2021.
- A 5-year average of -$13.0 million and a median of $19.0 million in 2023 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2021 and 2022: Change in Inventory plunged 212329714.98% in 2021, then soared 48545115.36% in 2022.
- Over 5 years, Change in Inventory stood at -$124.8 million in 2021, then declined by 18.37% to -$147.7 million in 2022, then jumped by 142.24% to $62.4 million in 2023, then plunged by 65.92% to $21.3 million in 2024, then jumped by 536.08% to $135.3 million in 2025.
- According to Business Quant data, Change in Inventory over the past three periods registered $135.3 million, $6.0 million, and $25.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -280,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 12.97 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 135.26 Mn |
| 10 | Roivant Sciences | 26.52 Bn | 26.52 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 135.26 Mn |
| Dec 31, 2025 | 135.26 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Jun 30, 2025 | 25.81 Mn |
| Jun 30, 2025 | 25.81 Mn |
| Mar 31, 2025 | 35.55 Mn |
| Mar 31, 2025 | 35.55 Mn |
| Dec 31, 2024 | 21.27 Mn |
| Dec 31, 2024 | 21.27 Mn |
| Sep 30, 2024 | 40.63 Mn |
| Sep 30, 2024 | 40.63 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 13.36 Mn |
| Mar 31, 2024 | 13.36 Mn |
| Dec 31, 2023 | 62.40 Mn |
| Dec 31, 2023 | 62.40 Mn |
| Sep 30, 2023 | 36.14 Mn |
| Sep 30, 2023 | 36.14 Mn |